Bottom line
How much do FBIOX and BIB overlap?
30% of their top holdings overlap by weight. 9 securities appear in both funds' top 25, making up 24.5% of FBIOX's assets and 18.5% of BIB's. They are substantially different portfolios, so owning both adds real diversification.
Updated Nov 22, 2026
Overlap at a glance
Holdings FBIOX and BIB have in common
| Holding | % of FBIOX | % of BIB | Overlap |
|---|---|---|---|
| Amgen Inc | 6.53% | 4.48% | 4.48% |
| Gilead Sciences Inc | 4.82% | 4.66% | 4.66% |
| Alnylam Pharmaceuticals Inc | 2.93% | 2.01% | 2.01% |
| Insmed Inc | 2.25% | 1.16% | 1.16% |
| Argenx Se | 2.25% | 1.19% | 1.19% |
| Revolution Medicines Inc | 2.02% | 1.57% | 1.57% |
| Moderna Inc | 1.28% | 0.94% | 0.94% |
| Biogen Inc | 1.26% | 1.44% | 1.26% |
| Roivant Sciences Ltd | 1.13% | 1.08% | 1.08% |
Source: SEC Form N-PORT (periods May 31, 2026 / May 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in FBIOX
- Krystal Biotech Inc — 10.58%
- Abbvie Inc — 9.22%
- Fidelity Revere Street Trust — 3.35%
- Praxis Precision Medicines Inc. — 2.47%
- Ascendis Pharma A/s — 2.04%
- Ucb Sa — 2.00%
- Jazz Pharmaceuticals Plc — 1.84%
- Scholar Rock Holding Corp — 1.55%
- Natera Inc — 1.41%
- Axsome Therapeutics Inc — 1.28%
- Protagonist Therapeutics Inc — 1.15%
- Cogent Biosciences Inc — 1.07%
- Tango Therapeutics Inc — 0.98%
- Celcuity Inc — 0.95%
- Madrigal Pharmaceuticals Inc — 0.93%
Only in BIB
- N/a — 7.35%
- ProShares GENIUS Money Market ETF — 6.80%
- Vertex Pharmaceuticals, Inc. — 4.65%
- N/a — 3.94%
- N/a — 3.26%
- Regeneron Pharmaceuticals, Inc. — 3.21%
- N/a — 2.62%
- Repurchase Agreement — 1.28%
- Illumina, Inc. — 1.25%
- United Therapeutics Corp. — 1.22%
- Royalty Pharma plc — 1.20%
- N/a — 1.18%
- Incyte Corp. — 0.97%
- Viatris, Inc. — 0.94%
- Guardant Health, Inc. — 0.85%
Asset mix
| Asset type | FBIOX | BIB |
|---|---|---|
| Stocks | 99.0% | 63.0% |
| Equity derivatives | — | 16.0% |
| Other | — | 6.8% |
| Cash & short-term funds | 3.5% | 0.8% |
| Repurchase agreements | — | 3.1% |
| Preferred stock | 0.9% | — |
Source: SEC Form N-PORT (periods May 31, 2026 / May 31, 2026)
Country mix
| Country | FBIOX | BIB |
|---|---|---|
| US | 88.5% | 79.8% |
| NL | 2.9% | 1.6% |
| DK | 2.6% | 0.8% |
| BE | 2.0% | — |
| IE | 2.0% | 1.2% |
| GB | 0.8% | 1.7% |
| BM | 1.1% | 1.1% |
| CH | 1.1% | 0.8% |
Source: SEC Form N-PORT (periods May 31, 2026 / May 31, 2026)
Check another pair
FAQ
How much do FBIOX and BIB overlap?
What stocks do FBIOX and BIB have in common?
Should I own both FBIOX and BIB?
Which holds more stocks, FBIOX or BIB?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.